Guard Therapeutics International AB Strategic Asset Allocation Index
Guard Therapeutics International AB strategic asset allocation index. Guard Therapeutics International AB (GUARD) has a Strategic Asset Allocation Index of 0.0% as of September 2025. Strategic assets (PP&E of Skr0.00 plus long-term investments of Skr-) total Skr0.00, measured against net assets of Skr55.63 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See GUARD equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guard Therapeutics International AB (2008–2024)
Strategic asset allocation index of Guard Therapeutics International AB from 2008 to 2024. This chart shows how Guard Therapeutics International AB's Strategic Asset Allocation Index has evolved across 15 annual periods from 2008 to 2024. As of September 2025, the index stands at 0.0%, representing strategic assets of Skr0.00 against net assets of Skr55.63 Million SEK. Check Guard Therapeutics International AB tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Guard Therapeutics International AB Strategic Asset Allocation Index by Year (2008–2024)
Guard Therapeutics International AB strategic asset allocation index by year from 2008 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Guard Therapeutics International AB from 2008 to 2024, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see GUARD market cap overview.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | Skr0.00 | Skr0.00 | Skr- | Skr37.97 Million | ▲ +0.0 pp |
| 2023 | 0.0% | Skr0.00 | Skr0.00 | Skr- | Skr66.73 Million | ▼ 0.0 pp |
| 2022 | 0.0% | Skr15.00K | Skr15.00K | Skr- | Skr177.36 Million | ▼ 0.0 pp |
| 2021 | 0.0% | Skr29.00K | Skr29.00K | Skr- | Skr175.78 Million | ▼ 0.0 pp |
| 2020 | 0.1% | Skr44.00K | Skr44.00K | Skr- | Skr79.69 Million | ▼ -0.9 pp |
| 2019 | 1.0% | Skr516.00K | Skr516.00K | Skr- | Skr52.62 Million | ▼ -1.4 pp |
| 2017 | 2.4% | Skr756.00K | Skr756.00K | Skr- | Skr31.96 Million | ▼ -1.4 pp |
| 2016 | 3.8% | Skr1.16 Million | Skr1.16 Million | Skr- | Skr30.34 Million | ▲ +0.9 pp |
| 2015 | 2.9% | Skr1.25 Million | Skr1.25 Million | Skr- | Skr42.69 Million | ▲ +1.7 pp |
| 2014 | 1.2% | Skr638.00K | Skr638.00K | Skr- | Skr52.25 Million | ▲ +0.2 pp |
| 2013 | 1.1% | Skr269.00K | Skr269.00K | Skr- | Skr25.42 Million | ▲ +1.0 pp |
| 2012 | 0.1% | Skr16.00K | Skr16.00K | Skr- | Skr30.58 Million | ▼ -0.4 pp |
| 2011 | 0.4% | Skr9.00K | Skr9.00K | Skr- | Skr2.12 Million | ▼ -0.1 pp |
| 2010 | 0.5% | Skr15.00K | Skr15.00K | Skr- | Skr3.08 Million | ▼ -0.5 pp |
| 2008 | 1.0% | Skr23.00K | Skr23.00K | Skr- | Skr2.34 Million | — |